GlassScriptPhysician profile
Justin D Harmon
NPI 1568562254
$2,338.34
in general payments reported to CMS, 2019-2025
32 companies · $567 in 2025
The $567 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $155 · 2021: $206 · 2022: $234 · 2023: $347 · 2024: $645 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.38 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.92 | 2024-2025 | |
| Medtronic, INC. | $396.94 | 2023-2025 | Interstim |
| Astellas Pharma US INC | $186.28 | 2019-2025 | Xtandi, Veozah |
| Boston Scientific Corporation | $156.04 | 2019-2024 | Lithoclast, Tria Firm, Ams 700 |
| Procept Biorobotics Corporation | $144.68 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $119.96 | 2024-2025 | |
| Janssen Biotech, INC. | $89.94 | 2019-2021 | |
| Myovant Sciences INC. | $68.81 | 2021-2022 | |
| Axogen | $67.93 | 2020 | |
| Axonics, INC. | $66.78 | 2022-2023 | Bulkamid |
| Coloplast Corp | $55.32 | 2023-2024 | Porges Coloplast, Speedicath |
| Agiliti Surgical, INC. | $52.67 | 2023 | Sonablate, Trinity |
| Teleflex LLC | $50.47 | 2022 | |
| Calyxo, INC. | $39.61 | 2024 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $38.82 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Specialty Pharmaceuticals, LLC | $38.01 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Allergan, INC. | $29.65 | 2019-2020 | |
| Olympus America INC. | $28.75 | 2024 | Itind System |
| Smith+Nephew, INC. | $27.31 | 2024 | Grafix Pl, Stravix Mesh, Stravix |
| Photocure INC | $25.86 | 2019 | |
| Intuitive Surgical, INC. | $20.83 | 2021 | |
| Urogen Pharma, INC. | $20.72 | 2020 | |
| Telix Pharmaceuticals | $20.31 | 2024 | Illuccix |
| Novartis Pharmaceuticals Corporation | $19.22 | 2024 | |
| Alnylam Pharmaceuticals INC. | $16.83 | 2024 | Oxlumo |
| Halozyme INC | $16.15 | 2023 | |
| Merck Sharp & Dohme LLC | $15.23 | 2022 | |
| Pfizer INC. | $14.30 | 2019 | |
| Urovant Sciences INC | $14.16 | 2022 | |
| Metuchen Pharmaceuticals | $13.57 | 2019 | |
| Cook Medical LLC | $13.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.